Achmea Investment Management B.V. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 41.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,570 shares of the medical equipment provider's stock after acquiring an additional 10,350 shares during the period. Achmea Investment Management B.V.'s holdings in Intuitive Surgical were worth $17,617,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in ISRG. Paragon Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at $1,008,000. Legacy CG LLC grew its holdings in Intuitive Surgical by 16.1% during the first quarter. Legacy CG LLC now owns 9,848 shares of the medical equipment provider's stock worth $4,877,000 after acquiring an additional 1,369 shares during the period. Artemis Investment Management LLP raised its position in Intuitive Surgical by 45.6% in the first quarter. Artemis Investment Management LLP now owns 78,337 shares of the medical equipment provider's stock worth $38,798,000 after acquiring an additional 24,548 shares in the last quarter. Transcend Capital Advisors LLC lifted its holdings in Intuitive Surgical by 2.3% in the 1st quarter. Transcend Capital Advisors LLC now owns 2,696 shares of the medical equipment provider's stock valued at $1,335,000 after acquiring an additional 61 shares during the last quarter. Finally, Trust Co. of Vermont boosted its position in shares of Intuitive Surgical by 0.7% during the 1st quarter. Trust Co. of Vermont now owns 5,130 shares of the medical equipment provider's stock valued at $2,541,000 after purchasing an additional 35 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.
Intuitive Surgical Stock Performance
Shares of ISRG stock opened at $534.19 on Friday. The company has a market capitalization of $191.46 billion, a price-to-earnings ratio of 78.33, a PEG ratio of 5.53 and a beta of 1.67. The stock's 50 day simple moving average is $531.06 and its 200 day simple moving average is $536.83. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter last year, the firm posted $1.50 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of brokerages recently weighed in on ISRG. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Citigroup reiterated a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Evercore ISI cut their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. Royal Bank Of Canada decreased their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Finally, Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $588.95.
Get Our Latest Stock Report on ISRG
Insiders Place Their Bets
In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,695,113.84. This represents a 3.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president now directly owns 2,245 shares of the company's stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last three months. Company insiders own 0.70% of the company's stock.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.